Overall, androgen‐independent CWR22RV1 and DU145 prostate cancer cells showed higher levels of IL6 expression compared to hormone‐responsive LNCaP and CWR22Res cells (Fig EV4F). This evidence concerns the gene IL6 and prostate cancer.